-

restor3d Raises $23 Million to Expand 3D Printed Personalized Solutions for Musculoskeletal Surgery and Develop Machine Learning Enabled Design Tools

DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leading medical device company and 3D printing manufacturer, has raised $23 million to expand the delivery of 3D printed personalized surgical solutions across multiple musculoskeletal specialties and to develop machine learning software tools for assisting engineers with patient specific implant design.

Ken Gall Ph.D., co-founder of restor3d and a Professor at Duke University, says the company will be deploying the capital on (1) new product introductions and enhanced 3D printed personalized surgical solutions in upper/lower extremity, spine, and trauma, (2) ongoing development of machine learning enabled software for surgical planning and implant design, (3) fundamental research, preclinical, and clinical studies, and (4) expansion of the commercial team to support market traction. In addition, in early 2023, restor3d will move into a new facility in Research Triangle Park that will expand capabilities for patient specific digital design, in-house manufacturing of implants and instruments, as well as surgeon training and education labs.

In 2021, restor3d announced it had merged with Kinos Medical, a leading total ankle replacement company, which helped accelerate restor3d’s expansion into the high-growth extremity arthroplasty markets in the U.S. restor3d has multiple FDA product clearances that span lower extremity, upper extremity, spine, and trauma. The new funding and restor3d’s 3D printed implant and disposable instrument model will enable simultaneous expansion across these diverse markets to provide innovative solutions for pressing clinical needs.

About restor3d:

Based in Durham, North Carolina, restor3d is a leading medical device company focused on enabling surgeons to improve the reconstruction and repair of the human body through 3D printed implants with enhanced anatomical fit and superior integrative properties. restor3d seeks to improve medical device solutions by leveraging expertise in 3D printing of advanced biomedical materials, anatomic and kinematic modeling, and AI based planning and design tools.

For more information, visit: http://www.restor3d.com.

Contacts

Lisa Marie Del Re, MPE, ATC, NASM-PES
Vice President of Marketing & Surgeon Engagement | restor3d
Ph: 208.724.7786 | E: lisamarie@restor3d.com

restor3d


Release Versions

Contacts

Lisa Marie Del Re, MPE, ATC, NASM-PES
Vice President of Marketing & Surgeon Engagement | restor3d
Ph: 208.724.7786 | E: lisamarie@restor3d.com

Social Media Profiles
More News From restor3d

restor3d Secures $38 Million in Growth Capital to Drive Expansion and Innovation in Personalized Orthopedic Solutions

DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in 3D printed, personalized orthopedic implant care, announced today the successful completion of capital raising efforts totaling $38 million. These funding rounds included participation from both existing and new private investors, including Summers Value Partners. The investments will fuel the company’s continued growth and the launch of four groundbreaking 3D printed product lines in 2025 and 2026. “From the beginning, our mission at restor3...

Title restor3d receives FDA Clearance for iTotal IdentityTM CR 3DP Porous Fully Personalized Total Knee Replacement System

DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in 3D-printed, personalized orthopedic implant care, has received FDA 510(k) clearance for the iTotal Identity™ CR 3DP Porous Total Knee Replacement System. This milestone marks a significant achievement in expanding restor3d’s knee replacement technology since the acquisition of Conformis, introducing the first cementless offering to the patient-specific implant portfolio. The company plans a limited market release in Q3 of 2025. The Identity 3...

restor3d Announces FDA Clearance of Ossera™ AFX Ankle Fusion System, Showcasing Innovations at ACFAS 2025

DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in 3D-printed, personalized orthopedic implant care, will showcase its latest foot and ankle innovations at the American College of Foot & Ankle Surgery (ACFAS) Annual Meeting in Phoenix, Ariz., from March 27-30, 2025. Among the highlights is the newly FDA 510(k)-cleared Ossera™ AFX Ankle Fusion System, engineered to advance fusion procedures through cutting-edge 3D printing and TIDAL Technology™. "We understand that every surgeon has unique...
Back to Newsroom